What is QuidelOrtho Corporation's EMEA — R&D?

QuidelOrtho Corporation (QDEL) reported EMEA — R&D of $400K in Q1 2026.

How has QuidelOrtho Corporation's EMEA — R&D changed year-over-year?

QuidelOrtho Corporation's EMEA — R&D decreased by 33.3% year-over-year, from $600K to $400K.

What is the long-term trend for QuidelOrtho Corporation's EMEA — R&D?

Over 3 years (2022 to 2025), QuidelOrtho Corporation's EMEA — R&D has grown at a 8.4% compound annual growth rate (CAGR), from $2.2M to $2.8M.

What does EMEA — R&D mean?

Reflects the expenditures dedicated to research and development activities specifically supporting the EMEA market's product portfolio. This indicates the company's commitment to regional innovation and product adaptation.

QuidelOrtho Corporation QDEL EMEA — R&D

Other segment segments

China

$700K-22.2%

Latin America

$500K+25.0%

North America

$400K0.0%

JPAC

$300K-25.0%

Similar metrics at other companies

TFX

TFXEMEA — Research and development expenses

$24.5M+257%

ZBHEMEA — Research And Development Expense Excluding Acquired In Process Cost

$1.7M-19.0%

VRTEurope, Middle East, & Africa — Engineering, research and development costs

$23M-1.3%

SSD

SSDEurope — Research And Development And Other Engineering Expense

$2.55M+19.7%

AEBIEurope and ROW — R&D

$5.07M+25.9%

WTSEurope — Research And Development Expense

$3M+30.4%

Other financials

Income statement

See full

Revenue$619.8M-10.5%

Gross profit$263.8M-23.2%

Operating income-$31.8M-198%

Net income-$91.8M-623%

EPS (diluted)-$1.35-611%

Balance sheet

See full

Cash & equivalents$140.4M+10.4%

Total debt$3.1B+0.3%

Total equity$1.9B-38.2%

Total assets$5.6B-12.9%

Cash flow

See full

Operating cash flow-$33.0M-150%

CapEx$34.0M-39.5%

Free cash flow-$67.0M-813%

Valuation

See full

Market cap$921.94M-51.4%

Enterprise value$3.88B-20.1%

P/S0.4×-0.3×

Profitability

See full

Gross margin45%-2.0pp

Operating margin-37%-46.2pp

Net margin-45.6%-75.7pp

FCF margin13.8%—

Returns & leverage

See full

Return on equity-49.9%-70.8pp

Debt / equity1.7×+0.6×

Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept qdel:SegmentInformationResearchAndDevelopmentExpense.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's emea — r&d.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is QuidelOrtho Corporation's EMEA — R&D?: QuidelOrtho Corporation (QDEL) reported EMEA — R&D of $400K in Q1 2026.
How has QuidelOrtho Corporation's EMEA — R&D changed year-over-year?: QuidelOrtho Corporation's EMEA — R&D decreased by 33.3% year-over-year, from $600K to $400K.
What is the long-term trend for QuidelOrtho Corporation's EMEA — R&D?: Over 3 years (2022 to 2025), QuidelOrtho Corporation's EMEA — R&D has grown at a 8.4% compound annual growth rate (CAGR), from $2.2M to $2.8M.
What does EMEA — R&D mean?: Reflects the expenditures dedicated to research and development activities specifically supporting the EMEA market's product portfolio. This indicates the company's commitment to regional innovation and product adaptation.